← Feed

ROSSI DINO A

SEC Form 4 insider
Krystal Biotech, Inc. ($KRYS)
1 thesis · first seen Aug 14, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d——————
3d——————
1w——————
1m——————
3m——————
6m——————
1y——————

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$KRYSSEC Form 4bearish
ROSSI DINO A · Krystal Biotech, Inc. · 3h agono track record yet
Sold 25,000 @ $329.12 avg · $8,227,953 · 2026-08-14

Form 4: ROSSI DINO A sold KRYS

ROSSI DINO A (Director at Krystal Biotech, Inc.) reported an open-market sale of 25,000 shares of KRYS at an average $329.12, roughly $8,227,953, in a Form 4 filed 2026-08-14.

View filing on SEC.gov →

End of results.